Danaher Corporation $DHR Shares Sold by State of Michigan Retirement System

State of Michigan Retirement System cut its stake in shares of Danaher Corporation (NYSE:DHR) by 4.5% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 164,546 shares of the conglomerate’s stock after selling 7,800 shares during the quarter. State of Michigan Retirement System’s holdings in Danaher were worth $37,668,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the company. Capital International Investors increased its stake in Danaher by 1.9% in the 3rd quarter. Capital International Investors now owns 16,758,240 shares of the conglomerate’s stock valued at $3,318,926,000 after buying an additional 312,951 shares during the period. Generation Investment Management LLP lifted its stake in shares of Danaher by 34.0% in the 3rd quarter. Generation Investment Management LLP now owns 6,654,666 shares of the conglomerate’s stock worth $1,319,354,000 after acquiring an additional 1,689,020 shares during the period. Legal & General Group Plc boosted its holdings in shares of Danaher by 5.0% in the third quarter. Legal & General Group Plc now owns 4,452,118 shares of the conglomerate’s stock valued at $882,677,000 after acquiring an additional 211,053 shares in the last quarter. Fisher Asset Management LLC boosted its holdings in shares of Danaher by 0.7% in the third quarter. Fisher Asset Management LLC now owns 4,369,219 shares of the conglomerate’s stock valued at $866,241,000 after acquiring an additional 28,583 shares in the last quarter. Finally, Massachusetts Financial Services Co. MA increased its stake in shares of Danaher by 104.7% during the fourth quarter. Massachusetts Financial Services Co. MA now owns 4,333,056 shares of the conglomerate’s stock worth $991,923,000 after acquiring an additional 2,216,789 shares during the period. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several research analysts recently issued reports on DHR shares. Guggenheim cut their price target on shares of Danaher from $275.00 to $235.00 and set a “buy” rating for the company in a report on Wednesday, April 22nd. The Goldman Sachs Group lowered their price objective on Danaher from $265.00 to $230.00 and set a “buy” rating on the stock in a report on Monday, April 13th. Barclays cut their target price on Danaher from $250.00 to $230.00 and set an “overweight” rating for the company in a research note on Tuesday, April 14th. Morgan Stanley reduced their price target on Danaher from $270.00 to $255.00 and set an “overweight” rating for the company in a report on Wednesday. Finally, Weiss Ratings restated a “hold (c)” rating on shares of Danaher in a research note on Friday, March 27th. Eighteen research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $240.70.

Danaher Stock Up 0.0%

Shares of NYSE DHR opened at $177.31 on Monday. The stock has a market capitalization of $125.49 billion, a price-to-earnings ratio of 34.30, a price-to-earnings-growth ratio of 2.37 and a beta of 0.95. Danaher Corporation has a 52 week low of $175.00 and a 52 week high of $242.80. The firm has a 50-day moving average price of $195.75 and a 200 day moving average price of $213.96. The company has a quick ratio of 1.52, a current ratio of 1.87 and a debt-to-equity ratio of 0.33.

Danaher (NYSE:DHR) last issued its earnings results on Tuesday, April 21st. The conglomerate reported $2.06 earnings per share for the quarter, topping the consensus estimate of $1.94 by $0.12. Danaher had a net margin of 14.89% and a return on equity of 10.91%. The company had revenue of $5.95 billion for the quarter, compared to analyst estimates of $6 billion. During the same period in the prior year, the business posted $1.88 earnings per share. The firm’s revenue for the quarter was up 3.7% compared to the same quarter last year. Danaher has set its FY 2026 guidance at 8.350-8.550 EPS. Equities research analysts anticipate that Danaher Corporation will post 8.43 EPS for the current fiscal year.

Danaher Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, April 24th. Shareholders of record on Friday, March 27th were issued a $0.40 dividend. This represents a $1.60 annualized dividend and a dividend yield of 0.9%. This is a boost from Danaher’s previous quarterly dividend of $0.32. The ex-dividend date of this dividend was Friday, March 27th. Danaher’s payout ratio is currently 30.95%.

Insider Activity at Danaher

In related news, EVP Gregory M. Milosevich sold 1,320 shares of the company’s stock in a transaction that occurred on Thursday, February 19th. The stock was sold at an average price of $208.01, for a total value of $274,573.20. Following the sale, the executive vice president owned 5,099 shares of the company’s stock, valued at approximately $1,060,642.99. This represents a 20.56% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 10.80% of the stock is owned by corporate insiders.

Trending Headlines about Danaher

Here are the key news stories impacting Danaher this week:

• Positive Sentiment: Guggenheim reiterated a Buy rating on Danaher, supporting demand-side interest from institutional buyers. Guggenheim Reaffirms Buy
• Positive Sentiment: An analyst price-target lift to $232 signals buy-side upside vs. current levels, which can support the stock if investors focus on medium-term earnings guidance. Price Target Raised to $232
• Neutral Sentiment: Danaher priced ~€3.0 billion of euro-denominated senior notes across maturities (2028–2038). This raises liquidity for operations or M&A but increases long-term debt on the balance sheet. Senior Notes Offering
• Neutral Sentiment: Coverage pieces question whether the recent share weakness makes DHR an attractive value play — useful for long-term investors but not an immediate catalyst. Valuation Article
• Negative Sentiment: Danaher agreed to settle shareholder litigation tied to its post‑pandemic outlook for about $172.5M, a direct hit to cash and a reminder of past forecasting issues; that likely pressured sentiment. Settlement Report
• Negative Sentiment: Short interest rose ~17.8% to 8.18M shares as of April 15 (≈1.3% of float; short-interest ratio ~2.5 days), indicating increased speculative/hedged bearish positioning that can amplify downward moves.
• Negative Sentiment: Morgan Stanley trimmed its price target (from $270 to $255), and UBS issued a pessimistic forecast—both moves add analyst-driven downside pressure despite differing target levels. Morgan Stanley PT Cut UBS Forecast
• Negative Sentiment: Analysts/commentary flag Danaher’s Masimo acquisition as adding long-term potential but creating near-term margin and integration pressure, a nearer-term risk to earnings momentum. Masimo Deal Commentary

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.